Responsiveness of the Colombian Spanish Version of the DLQI in Psoriasis Patients With Biologic Therapy

Responsiveness of the Colombian Spanish Version of the DLQI in Psoriasis Patients With Biologic Therapy

Bibliographische Detailangaben
Hauptverfasser:	M.F. Tibaduiza, Y.K. Berbeo, C.M. Ton, D.C. Aguirre-Acevedo, G. Sanclemente
Format:	Artikel
Sprache:	English
Veröffentlicht:	Elsevier 2024-03-01
Schriftenreihe:	Actas Dermo-Sifiliográficas
Online Zugang:	http://www.sciencedirect.com/science/article/pii/S0001731023008268

Ähnliche Einträge

[Artículo traducido] Capacidad de respuesta de la versión en español colombiano del DLQI en pacientes con psoriasis en terapia biológica
von: M.F. Tibaduiza, et al.
Veröffentlicht: (2024-03-01)

Sex Differences in Dermatology Life Quality Index (DLQI) among Patients with Psoriasis
von: Mikkel Bak Jensen, et al.
Veröffentlicht: (2024-12-01)

Validation and application of the Dermatology Life Quality Index score, a modification of the DLQI score, in psoriasis patients
von: Qin Zou, et al.
Veröffentlicht: (2024-06-01)

Application of Dermatology Life Quality Index‐Relevant (DLQI‐R) in patients with moderate‐to‐severe plaque psoriasis treated with tildrakizumab
von: Philip Laws, et al.
Veröffentlicht: (2023-12-01)

Exploring the Correlation between the PASI and DLQI Scores in Psoriasis Treatment with Topical Ointments Containing <i>Rosa × damascena</i> Mill. Extract
von: Diana Ioana Gavra, et al.
Veröffentlicht: (2024-08-01)

Measurement Equivalence and Feasibility of the Electronic and Paper Versions of the POSAS, EQ-5D, and DLQI: A Randomized Crossover Trial
von: Jill Meirte, et al.
Veröffentlicht: (2024-10-01)

Validity and reliability of Spanish version of the EQ-i: YV[S] in Colombian children and youth
von: Claudia Patricia Navarro Roldán, et al.
Veröffentlicht: (2023-04-01)

Differential access to psoriasis biologic information in English and Spanish
von: Max Oscherwitz, BS, et al.
Veröffentlicht: (2024-06-01)

Comparison of three quality of life instruments in lymphatic filariasis: DLQI, WHODAS 2.0, and LFSQQ.
von: Cristina Thomas, et al.
Veröffentlicht: (2014-02-01)

Validation of the DLQI questionnaire in assessing the disease burden and principal aspects related to life quality of vitiligo patients
von: Laszlo Fekete, et al.
Veröffentlicht: (2024-05-01)

Quality of life in patients with scabies: A cross‐sectional study using Dermatology Life Quality Index (DLQI) questionnaire
von: Sushil Paudel, et al.
Veröffentlicht: (2023-06-01)

British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017
von: Smith, CH, et al.
Veröffentlicht: (2017)

Spanish as an argument-indexing language. A view from the analysis of Colombian Andean Spanish
von: Sergio Ibáñez Cerda, et al.
Veröffentlicht: (2023-12-01)

Validation of a Latin-American Spanish version of the Body Esteem Scale for Adolescents and Adults (BESAA-LA) in Colombian and Nicaraguan adults
von: Fabienne E. Andres, et al.
Veröffentlicht: (2023-12-01)

The conceptions of Spanish and Colombian students regarding processes of historical reconciliation
von: Nilson Javier Ibagón, et al.
Veröffentlicht: (2024-01-01)

Validation of the Colombian version of the Karolinska sleepiness scale
von: María Camila Laverde-López, et al.

Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta-analysis
von: Mahil, SK, et al.
Veröffentlicht: (2020)

British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: A rapid update
von: Smith, CH, et al.
Veröffentlicht: (2020)

The Digital Self-Efficacy Scale: Adaptation and Validation of Its Spanish Version
von: Milton Paredes-Aguirre, et al.
Veröffentlicht: (2024-01-01)

British Association of Dermatologists guidelines for biologic therapy for psoriasis 2023 - a pragmatic update.
von: Smith, CH, et al.
Veröffentlicht: (2023)

Understanding the impact of acne vulgaris and associated psychological distress on self-esteem and quality of life via regression modeling with CADI, DLQI, and WHOQoL
von: A. S. M. Morshed, et al.
Veröffentlicht: (2023-11-01)

Psychometric characteristics of the Spanish version of the HIV Symptom Index
von: Olatz Ibarra-Barrueta, et al.
Veröffentlicht: (2024-10-01)

Pharmacogenetics Update on Biologic Therapy in Psoriasis
von: Ester Muñoz-Aceituno, et al.
Veröffentlicht: (2020-12-01)

Responsiveness of the Spanish Version of the “Skin Cancer Index”
von: M. de Troya-Martín, et al.
Veröffentlicht: (2016-01-01)

Self-Supervised Sentiment Analysis in Spanish to Understand the University Narrative of the Colombian Conflict
von: Paula Rendón-Cardona, et al.
Veröffentlicht: (2022-05-01)

Clinical evidence of therapy for genital psoriasis by biologic agents
von: Evgeny V. Sokolovskiy, et al.
Veröffentlicht: (2021-04-01)

Dermatology Life Quality Index (DLQI) Score in Acne Vulgaris after Epigallocatechin-3-Gallate (EGCG) 3% as an Adjuvant of Tretinoin 0,025% Cream
von: Farah Meriana Fajrin, et al.
Veröffentlicht: (2023-11-01)

Citation rates for bilingual English/Spanish Colombian medical publications: a natural experiment
von: Juan Felipe Torres García, et al.
Veröffentlicht: (2021-01-01)

A Case of Paradoxical Reactions to Biologic Therapy for Psoriasis
von: Zhou Q, et al.
Veröffentlicht: (2023-06-01)

Spanish version of the Parkinson's Disease Questionnaire-Carer (PDQ-Carer)
von: Ferrer-Cascales, R, et al.
Veröffentlicht: (2016)

Efficacy and Duration of Biological Therapies among Saudi Patients with Psoriasis
von: Sami N. Alsuwaidan, et al.
Veröffentlicht: (2024-12-01)

Dose reduction of biologics in patients with plaque psoriasis: a review
von: C. A. M. van Riel, et al.
Veröffentlicht: (2024-03-01)

Systemic treatment of psoriasis: from methotrexate to biologics
von: Olga Yu. Olisova, et al.
Veröffentlicht: (2020-09-01)

Early predictors of efficacy of biological therapy for psoriasis in children
von: D. G. Kuptsova, et al.
Veröffentlicht: (2023-04-01)

Biological Therapy Survivability in Children with Psoriasis: Cohort Study
von: Roman A. Ivanov, et al.
Veröffentlicht: (2021-11-01)

Biological therapy in the reduction of cardiovascular risk in patients with psoriasis
von: Andrés Tirado-Sánchez
Veröffentlicht: (2025-01-01)

The use of dual biologic therapy for the management of recalcitrant psoriasis
von: Paula Finnegan, BA, MB, BAO, BCh, MRCPI, et al.
Veröffentlicht: (2024-05-01)

Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
von: Mitchell S. Davis, et al.
Veröffentlicht: (2023-12-01)

When should systemic biologic therapy for psoriasis be discontinued?
von: Diem-Phuong D. Dao, et al.
Veröffentlicht: (2023-01-01)

Management Strategies for Pediatric Moderate-to-Severe Plaque Psoriasis: Spotlight on Biologics
von: Ruggiero A, et al.
Veröffentlicht: (2023-11-01)